Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1985-03-11
1987-02-03
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
A61K 4904
Patent
active
046408339
ABSTRACT:
Method of X-raying animals using as a contrast agent a perfluorobromoalkyl ether of the formula C.sub.m F.sub.2m+1 OC.sub.n F.sub.2n Br where m and n independently are integers of from 2 to 6, wherein the ether is used either neat or in an aqueous dispersion such as an emulsion.
REFERENCES:
patent: 3453333 (1969-07-01), Litt et al.
patent: 3778381 (1970-12-01), Rosand et al.
patent: 3975512 (1976-08-01), Long
patent: 4285928 (1981-08-01), Wada
patent: 4490351 (1984-12-01), Clark
Biochemistry Involving Carbon-Fluorine Bonds, edited by Robert Filler, ACS Symposium Series No. 28, 1976, Chapter 9.
"The Synthesis and Biological Screening of New and Improved Fluorocarbon Compounds for Use as Artificial Blood Substitutes".
Clark, Jr. Leland C.
Tamborski Christ
Adamantech, Inc.
Back Stanford M.
Children's Hospital Research Foundation
Hess J. Edward
Johnson Donald R.
LandOfFree
Use of perfluorobromoalkyl ethers as X-ray contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of perfluorobromoalkyl ethers as X-ray contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of perfluorobromoalkyl ethers as X-ray contrast agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1091022